[go: up one dir, main page]

NO973401L - Kortikosteroidinneholdende sammensetninger og fremstilling derav - Google Patents

Kortikosteroidinneholdende sammensetninger og fremstilling derav

Info

Publication number
NO973401L
NO973401L NO973401A NO973401A NO973401L NO 973401 L NO973401 L NO 973401L NO 973401 A NO973401 A NO 973401A NO 973401 A NO973401 A NO 973401A NO 973401 L NO973401 L NO 973401L
Authority
NO
Norway
Prior art keywords
corticosteroid
preparation
containing compositions
liposomes
contained
Prior art date
Application number
NO973401A
Other languages
English (en)
Other versions
NO973401D0 (no
Inventor
Peter William Taylor
Janet Catherine Maas
Original Assignee
Ciba Geigy Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy Ag filed Critical Ciba Geigy Ag
Publication of NO973401L publication Critical patent/NO973401L/no
Publication of NO973401D0 publication Critical patent/NO973401D0/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/568—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0078—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a nebulizer such as a jet nebulizer, ultrasonic nebulizer, e.g. in the form of aqueous drug solutions or dispersions

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Dispersion Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

Farmasøytisk sammensetning, omfattende som aktivt ingrediens en forbindelse med formel (I). inneholdt i liposomer eller dehydrerte liposomer.
NO973401A 1995-01-24 1997-07-23 Kortikosteroidinneholdende sammensetninger og fremstilling derav NO973401D0 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9501286.0A GB9501286D0 (en) 1995-01-24 1995-01-24 Pharmaceutical compositions and preparations thereof
PCT/GB1996/000083 WO1996022764A1 (en) 1995-01-24 1996-01-17 Liposomes containing a corticosteroid

Publications (2)

Publication Number Publication Date
NO973401L true NO973401L (no) 1997-07-23
NO973401D0 NO973401D0 (no) 1997-07-23

Family

ID=10768424

Family Applications (1)

Application Number Title Priority Date Filing Date
NO973401A NO973401D0 (no) 1995-01-24 1997-07-23 Kortikosteroidinneholdende sammensetninger og fremstilling derav

Country Status (10)

Country Link
EP (1) EP0859598A1 (no)
JP (1) JPH10512876A (no)
CN (1) CN1169115A (no)
AU (1) AU4396196A (no)
CA (1) CA2210482A1 (no)
CZ (1) CZ234297A3 (no)
FI (1) FI973049L (no)
GB (1) GB9501286D0 (no)
NO (1) NO973401D0 (no)
WO (1) WO1996022764A1 (no)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6344576B1 (en) 1997-08-18 2002-02-05 MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. Phospholipid-analogous compounds
GB9912639D0 (en) 1999-05-28 1999-07-28 Britannia Pharmaceuticals Ltd Improvements in and relating to treatment of respiratory conditions
EP1133301A1 (en) * 1998-11-26 2001-09-19 Britannia Pharmaceuticals Limited Anti-asthmatic combinations comprising surface active phospholipids
PT1180017E (pt) 1999-05-27 2010-05-28 Euro Celtique Sa Preparações com povidona-iodo para o tratamento de feridas
US7300667B1 (en) 1999-05-27 2007-11-27 Euro-Celtique, S.A. Preparations for the application of anti-inflammatory, especially antiseptic agents and/or agents promoting the healing of wounds, to the lower respiratory tract
AU2001241045A1 (en) * 2000-03-09 2001-09-17 Kissei Pharmaceutical Co. Ltd. Preventive or therapeutic drugs for eye diseases
GB0029562D0 (en) * 2000-12-04 2001-01-17 Novartis Ag Organic compounds
DE10255285A1 (de) * 2002-11-26 2004-06-03 Mcs Micro Carrier Systems Gmbh Selbst formende Phospholipid-Gele
KR101411758B1 (ko) * 2006-09-05 2014-06-25 큐피가부시키가이샤 프로스태글란딘 지방 에멀젼, 이의 제조 방법, 그 에멀젼의안정화 방법 및 에멀젼화제

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4607028A (en) * 1983-08-18 1986-08-19 Ciba-Geigy Corporation Novel carboxylic acid esters
US5192528A (en) * 1985-05-22 1993-03-09 Liposome Technology, Inc. Corticosteroid inhalation treatment method
SE8603812D0 (sv) * 1986-09-12 1986-09-12 Draco Ab Administration of liposomes to mammals
US5043165A (en) * 1988-12-14 1991-08-27 Liposome Technology, Inc. Novel liposome composition for sustained release of steroidal drugs

Also Published As

Publication number Publication date
CZ234297A3 (en) 1997-10-15
CA2210482A1 (en) 1996-08-01
JPH10512876A (ja) 1998-12-08
FI973049A7 (fi) 1997-07-18
WO1996022764A1 (en) 1996-08-01
MX9705592A (es) 1997-11-29
NO973401D0 (no) 1997-07-23
CN1169115A (zh) 1997-12-31
GB9501286D0 (en) 1995-03-15
AU4396196A (en) 1996-08-14
FI973049A0 (fi) 1997-07-18
EP0859598A1 (en) 1998-08-26
FI973049L (fi) 1997-07-18

Similar Documents

Publication Publication Date Title
KR890700125A (ko) 신규 벤즈이미다졸 유도체, 그 제조방법 및 이 화합물을 함유하는 제약 조성물
NO971889D0 (no) Forbindelser og sammensetninger for levering av aktive midler
MY115339A (en) Compositions containing micronized nebivolol
AU5669298A (en) Cyclosporin derivatives, their preparation and pharmaceutical compositions containing them
AU5669398A (en) Novel cyclosporin derivatives, method of preparation and pharmaceutical compositions containing them
SE9504661D0 (sv) New compounds
AU5669198A (en) Cyclosporin derivative, its preparation and pharmaceutical compositions containing same
SE8804629D0 (sv) New therapeutically active compounds
MY101791A (en) New benzimidazole derivatives
MD1233C2 (ro) Derivaţi de eritromicină, procedeu de preparare a lor şi compoziţie farmaceutică pe baza acestora
NO954072D0 (no) Vannopplöselige camptotecinderivater, fremgangsmåte for deres fremstilling og deres anvendelse som antitumormidler
IL94433A0 (en) Aminophenol derivatives,their preparation and pharmaceutical compositions containing them
ES2002140A6 (es) Procedimiento para producir preparados de derivados de acido arilpropionico resorbibles por via transdermal y acuosos
UA48958C2 (uk) 9-o-оксимові похідні еритроміцину а та фармацевтична композиція на їх основі
FI945780A7 (fi) Uudet biologisesti aktiiviset eburnameniinijohdannaiset, niitä sisältävät farmaseuttiset koostumukset ja menetelmä niiden valmistamiseksi
FI943645A7 (fi) Uusia bakkatiini-III ja 10-deasetyylibakkatiini-III-johdannaisia, niid en valmistus ja niitä sisältäviä farmaseuttisia koostumuksia
NO973401L (no) Kortikosteroidinneholdende sammensetninger og fremstilling derav
PH27446A (en) Compound with gastric acid inhibitory effect
DE69819539D1 (de) Antithrombotische mittel
SE9504662D0 (sv) New compounds
CA2263846A1 (en) Novel pyranoside derivatives
SE9403137D0 (sv) Derivatives of carbohydrates and compositions containing them
AU7470098A (en) Antithrombotic agents
NO960812L (no) Alkoksysubstituerte ptoren
DE69829849D1 (de) Streptograminderivate, ihre herstellung und sie enthaltende zubereitungen

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application